Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ET Company Participants Tim McCarthy - LifeSci Advisors Sergio Traversa - CEO Cedric O'Gorman - Chief Medical Officer Maged Shenouda - CFO Conference Call Participants Rudy Li - Leerink Partner Andrea Tan - Goldman Sachs Operator Greetings, and welcome to Relmada Therapeutics Inc. Second Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It's now my p ...